Stockscreener 앱 받기
2.32
6.07%
-0.15
Zentalis Pharmaceuticals Inc 주식(ZNTL)의 최신 뉴스
Zentalis Pharmaceuticals (ZNTL): Among Cheapest Stocks Insiders Are Buying Recently - Yahoo Finance
Savant Capital LLC Acquires New Shares in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc.ZNTL - PR Newswire
Zentalis stock plunges to 52-week low, hits $2.16 - MSN
Zentalis Pharmaceuticals' chief medical officer acquires $45,656 in stock - MSN
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives $8.24 Consensus PT from Brokerages - MarketBeat
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Insider Ingmar Bruns Buys 20,000 Shares - MarketBeat
What is Leerink Partnrs' Forecast for ZNTL Q3 Earnings? - MarketBeat
Zentalis Pharmaceuticals' chief medical officer acquires $45,656 in stock By Investing.com - Investing.com Australia
Zentalis Pharmaceuticals’ chief medical officer acquires $45,656 in stock By Investing.com - Investing.com Nigeria
Chief Medical Officer Bruns Ingmar bought $45,656 worth of shares (20,000 units at $2.28), increasing direct ownership by 120% to 36,629 units (SEC Form 4) - Quantisnow
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus Rating of “Hold” by Analysts - Defense World
Q1 Earnings Estimate for ZNTL Issued By Leerink Partnrs - MarketBeat
What is Leerink Partnrs’ Estimate for ZNTL Q3 Earnings? - Defense World
Zentalis Pharmaceuticals executive sells shares worth $4,475 - MSN
Potential Price Increase for Zentalis Pharmaceuticals Inc (ZNTL) After Recent Insider Activity - Knox Daily
SG Americas Securities LLC Buys 30,240 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Zentalis Pharmaceuticals Inc’s (ZNTL) Stock: A Week-by-Week Analysis - The News Heater
Zentalis Pharmaceuticals Inc (ZNTL) Stock: A Year of Highs and Lows - The InvestChronicle
Insider Buying: Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Director Acquires 60,000 Shares of Stock - MarketBeat
Zentalis pharmaceuticals director Jan Skvarka buys $103,446 in stock - MSN
Analysts Issue Forecasts for ZNTL Q1 Earnings - Defense World
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) Stock Falling -30.99% Over A Month – Any Room For Its Value To Rise? - Marketing Sentinel
Insider Buying: Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Director Purchases $103,200.00 in Stock - Armenian Reporter
Zentalis Pharmaceuticals chief legal officer sells $22,643 in stock - MSN
HC Wainwright Has Bullish Estimate for ZNTL Q1 Earnings - MarketBeat
Zentalis pharmaceuticals officer sells $24,590 in stock - MSN
Zentalis Pharmaceuticals executive sells shares worth $4,475 By Investing.com - Investing.com Australia
FY2024 Earnings Forecast for ZNTL Issued By Leerink Partnrs - MarketBeat
Zentalis Pharmaceuticals Llc Stock: Executives Sell Shares Amid Market Volatility - sharewise
High-Profile Executives Make Bold Moves with Zentalis Pharmaceuticals Stock - TipRanks
Zentalis pharmaceuticals officer sells $24,590 in stock By Investing.com - Investing.com Nigeria
Analysts review Zentalis Pharmaceuticals Inc’s rating - Knox Daily
Zentalis Pharmaceuticals Inc (ZNTL) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
Zentalis pharmaceuticals director Luke Walker buys $24,966 in stock - MSN
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) -2.98% Decline Turns Investors Away - Stocks Register
Millennium Management LLC Acquires Significant Stake in Zentalis Pharmaceuticals Inc - GuruFocus.com
Top Executives Show Strong Confidence in Zentalis Pharmaceuticals with Major Stock Buys - TipRanks
0.27%
3.05%
자본화:
|
볼륨(24시간):